Development of skin cell regeneration technology Beauty Tech startup
New Paradigm Investment announced on the 1st that it has built a seed investment in Curapulse, a beauty tech start-up that develops skin cell regeneration technology.
Curapulse is a beauty tech startup that is pursuing technology advancement centered on skin cell regeneration technology utilizing ultrasonic, pulse, and light complex energy. Based on ultrasonic long-distance focutilizing, low-frequency, and multi-cross ultrasonic driving and analysis technologies, the commercialization of skin care devices is in full swing, and a number of preclinical and human clinical data are accumulated.
As for skin care technology, it has core technologies based on complex energy developed by itself, such as cell stimulation technology wave sink for skin regeneration, dual formation that maximizes active ingredient delivery, and intranasonic that increases the absorption rate of oral ingestion components. This technology was applied to the representative home beauty device ‘DualTetra’ series.
Park Je-hyun, co-chairman of New Paradigm Investment, declared, “We highly appreciated the potential to lead innovation in the global beauty tech industest beyond K-beauty through a differentiated technology-oriented approach.”
Currently, Curapulse plans to release a substantial product of its skin care device ‘DualTetra’ at the finish of the year and is actively discussing OEM/ODM partners to enter the European and North American markets. In the Japanese market, the introduction to acquireers was completed through the Toyota Tzuyu Show, and initial sales are taking place in the United States. In addition, it is rapidly expanding sales in the B2C market through its sales strategy through the MCN (influencer Marketing) channel, and has signed an MOA with EDA Technology to enter the Chinese and Chinese markets and is starting its business in earnest.
“We will leap to become a global leader in skin health with innovative technology based on scientific evidence,” declared Cho Nam-kyu, CEO of Curapulse. “Based on this investment, we will lead the next generation of K-beauty tech innovation by accelerating technology advancement and entest into overseas markets.”
CEO Cho has accumulated expertise in the field of ultrasonic medical device technology-based device development over the past seven years, and is expanding the global market, including North America and Europe, based on his practical experience of leading new B2B and B2C projects and successfully leading global projects worth more than 100 billion won during his tenure at Humax.

![Bae Sang-seung, co-chairman of New Paradigm Investment, Cho Nam-gyu, CEO of Curapulse, and Park Je-hyun, co-chairman of New Paradigm Investment (from left), are taking commemorative photos. [New Paradigm Investment]](https://foundernews.eu/storage/2025/09/news-p.v1.20250901.1d0521d0f7c7412a8c74f7f2aa87aca9_P1.jpg)













Leave a Reply